Activase May Be Reclassified With Separate DRG Under Medicare Part A
The Centers for Medicare & Medicaid Services is considering the creation of a separate diagnosis-related group for the use of drugs like Genentech's Activase to treat ischemic strokes under Medicare Part A
You may also be interested in...
A new Medicare hospital payment category covering Guilford's Gliadel Wafer is expected to raise the reimbursement rate for the chemotherapy implant effective Oct. 1
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials